Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma.

Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, et al.

Blood. 1993 Jun 15;81(12):3449-57.

2.
3.

Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.

Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.

Neoplasma. 2001;48(6):501-5.

PMID:
11949845
4.

Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease.

Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG.

Blood. 1997 Nov 15;90(10):4212-21.

6.
7.

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, et al.

N Engl J Med. 1991 Nov 28;325(22):1525-33.

10.
11.

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.

Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM.

Blood. 1996 Oct 1;88(7):2780-6.

12.

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.

Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S.

Bone Marrow Transplant. 1999 Oct;24(8):865-72.

13.

PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.

Vervoordeldonk SF, Merle PA, Behrendt H, Steenbergen EJ, van den Berg H, van Wering ER, von dem Borne AE, van der Schoot CE, van Leeuwen EF, Slaper-Cortenbach IC.

Br J Haematol. 1997 Feb;96(2):395-402.

PMID:
9029032
14.

Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.

Moos M, Schulz R, Cremer F, Sucker C, Schmohl D, Döhner H, Goldschmidt H, Haas R, Hunstein W.

Stem Cells. 1995 Dec;13 Suppl 3:42-51.

PMID:
8747988
15.

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.

Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossman R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG.

Blood. 1999 Nov 15;94(10):3325-33.

16.

Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.

Macintyre EA, Belanger C, Debert C, Canioni D, Turhan AG, Azagury M, Hermine O, Varet B, Flandrin G, Schmitt C.

Blood. 1995 Dec 15;86(12):4691-8.

17.
18.

Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation.

Miglino M, Santini G, Grasso R, Pietrasanta D, Clavio M, Pierri I, Canepa L, Nati S, Ballerini F, Varaldo R, Palmisano G, Gobbi M.

Haematologica. 2001 Jul;86(7):706-14.

19.
20.

Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.

Kornacker M, Kornacker B, Schmitt C, Leo E, Ho AD, Hensel M.

Ann Hematol. 2009 Jan;88(1):43-50. doi: 10.1007/s00277-008-0550-4. Epub 2008 Jul 18.

PMID:
18636259

Supplemental Content

Support Center